Show simple item record

dc.contributor.advisorStruck, H.C.en_US
dc.contributor.authorMitchell, Robert Alexander Jr.en_US
dc.date.accessioned2018-09-26T16:11:42Z
dc.date.available2018-09-26T16:11:42Z
dc.date.issued1952en_US
dc.identifier.urihttp://hdl.handle.net/10504/119336
dc.description.abstractIn 1924 Huyghebaert first reported the hemolytic action of methylene blue.(l) Later, in 1934, Wendel and Hefley (2) studied the anemia produced in dogs by single large doses of methylene blue, and suggested that the dye might be useful in treating polycythemia vara, They noted that the drug did not cause immediate hemolysis, but that the maximum anemia developed four to seven days after a single dose of methylene blue mas given, and that the dogs recovered in about two weeks. Another effect of methylene blue noted by these investigators was the formation of Heints bodies in the erythrocytes. In 1947 McLimans and Grant (3) who were studying the use of methylene blue in the treatment of tsutsugamushi fever, found that methylene blue reduced the mortality in rats infected with this disease, but that the rats often succumbed because of anemia.en_US
dc.language.isoen_USen_US
dc.publisherCreighton Universityen_US
dc.rightsA non-exclusive distribution right is granted to Creighton University and to ProQuest following the publishing model selected above.en_US
dc.titleThe Production of Anemia in Dogs with Methylene Blueen_US
dc.typeThesis
dc.publisher.locationOmaha, Nebraskaen_US
dc.description.noteProQuest Traditional Publishing Optionen_US
dc.contributor.cuauthorMitchell, Robert Alexander Jr.en_US
dc.degree.levelMS (Master of Science)en_US
dc.degree.disciplinePhysiology (graduate program)en_US
dc.degree.nameM.S. in Physiologyen_US
dc.degree.grantorGraduate Schoolen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record